| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/14/2006 | WO2005117936A3 Method for enhancing or inhibiting insulin-like growth factor-i |
| 09/14/2006 | WO2005115136A3 Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases |
| 09/14/2006 | WO2005114225A3 Method and apparatus for determining the efficiency of a vaporizer in a decontamination system |
| 09/14/2006 | WO2005112565A3 Preparation of nanometric arrays of biomolecules on oligo- or poly(ethylene glycol) films on silicon surfaces |
| 09/14/2006 | WO2005109304A8 Small molecules and a pharmacophore model for inhibition of anthrax lethal factor |
| 09/14/2006 | WO2005109000A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 09/14/2006 | WO2005105093A3 METHOD OF ARRESTING THE SIDE EFFECTS OF µ-OPIOID RECEPTOR AGONISTS DURING THEIR ADMINISTRATION |
| 09/14/2006 | WO2005103694A3 Methods and fish models for identifying agents for treating bone and joint disease |
| 09/14/2006 | WO2005100982A3 Methods for stabilizing 5-azacytidine in plasma |
| 09/14/2006 | WO2005094291A3 Computational selection of probes for localizing chromosome breakpoints |
| 09/14/2006 | WO2005086875A3 A humanized anti-cea t84.66 antibody and uses thereof |
| 09/14/2006 | WO2005084279A3 Systems and methods for disease diagnosis |
| 09/14/2006 | WO2005084171A3 Systems and methods for analyzing gene expression data for clinical diagnostics |
| 09/14/2006 | WO2005070086A3 Methods and compositions for determining a graft tolerant phenotype in a subject |
| 09/14/2006 | WO2005007121A3 Mutant interleukin-2(il-2) polypeptides |
| 09/14/2006 | WO2004005462A3 Reagents and methods for identifying and modulating expression of tumor senescence genes |
| 09/14/2006 | WO2003089588A3 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 09/14/2006 | WO2003072759A3 Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers |
| 09/14/2006 | WO2003002721A3 Compositions and methods for inferring a response to a statin |
| 09/14/2006 | US20060206950 In vivo imaging of e2f-fegulated bioluminescent proteins |
| 09/14/2006 | US20060206034 Breath alcohol measuring device with improved mouthpiece |
| 09/14/2006 | US20060206016 Device for collecting skin permeable gas and apparatus for measuring skin permeable gas |
| 09/14/2006 | US20060206015 Device for collecting skin permeable gas and apparatus for measuring skin permeable gas |
| 09/14/2006 | US20060205934 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 09/14/2006 | US20060205925 Inhibits hemolysis by interacting with the plasma proteins clusterin; histidine rich glycoprotein (HRG); Streptococcal Inhibitor of Complement-mediated lysis |
| 09/14/2006 | US20060205760 Molecules and methods for fluorescence microscopy |
| 09/14/2006 | US20060205724 Antagonizing nk-1 receptors inhibits consumption of substances of abuse |
| 09/14/2006 | US20060205665 Non-basic amino acid sequence transporter peptide conjugated to biological effector; translocation across the membrane of eukaryotic cells |
| 09/14/2006 | US20060205650 Treatment of neuropsychiatric disease with protease and neuraminidase inhibitors |
| 09/14/2006 | US20060205645 Administering a vascular endothelial growth factor (VEGF120, VEGF188 or VEGF165); intra-uterine or intra-amniotically to a fetus; intra-tracheal to a neonate |
| 09/14/2006 | US20060205094 Methods using novel chemiluminescent labels |
| 09/14/2006 | US20060205093 Use of magnetic particles for determining binding between bioactive molecules |
| 09/14/2006 | US20060205092 Bioanalysis systems including optical integrated circuit |
| 09/14/2006 | US20060205091 Protein biopolymer markers predictive of insulin resistance |
| 09/14/2006 | US20060205090 Water-soluble conjugates for electrochemical detection |
| 09/14/2006 | US20060205089 Mapping discontinuous antibody or aptamer epitopes for protein structure determination and other applications |
| 09/14/2006 | US20060205088 Agglutination Assay Method in Porous Medium Layer |
| 09/14/2006 | US20060205087 Porous membrane with wicking pad; sample application and trigger generation zones in which analyte reacts to produce hydrogen peroxide; detection zone with immobilized chromophore reacting with hydrogen peroxide to generate visible signal; scavenging zone attenuates signal; di- and triarylmethane dyes |
| 09/14/2006 | US20060205086 Diagnostic device |
| 09/14/2006 | US20060205084 Reducing toxicity associated with 6-mercaptopurine drug treatment via monitoring concentration of 6-thioguanine in blood; treating inflammatory bowel disease |
| 09/14/2006 | US20060205083 Determining chemical oxygen demand of a water sample using a titanium dioxide nanoparticulate semiconductive electrode; assay apparatus |
| 09/14/2006 | US20060205082 Reaction rate determination |
| 09/14/2006 | US20060205072 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 09/14/2006 | US20060205069 Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cells |
| 09/14/2006 | US20060205054 DNA encoding a Tumor Antigen Derived Gene-14 (TADG-14) protein which is overexpressed in ovarian, breast and colon carcinoma; for detecting and targeting of these carcinomas |
| 09/14/2006 | US20060205052 Bardet-Biedl susceptibility gene and uses thereof |
| 09/14/2006 | US20060205033 Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 09/14/2006 | US20060205029 Device for the determination of glycated hemoglobin |
| 09/14/2006 | US20060205025 Rapid prion-detection assay |
| 09/14/2006 | US20060205024 Method to diagnose and evaluate progression of Alzheimer's disease |
| 09/14/2006 | US20060205023 In vitro; transcription factors; competitive binding; ELISA; immunoassay; immunohistochemistry |
| 09/14/2006 | US20060205022 Method for diagnosing and prognosing inflammatory bowel disease and crohn's disease |
| 09/14/2006 | US20060205021 Mammalian IAP gene family, primers, probes and detection methods |
| 09/14/2006 | US20060205020 Cell-cycle checkpoint genes |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060205016 Protein a based binding domains with desirable activities |
| 09/14/2006 | US20060205015 Method for detecting the interactions between a G protein-coupled receptor (GPCR) and one of the Galpha or Gbetagamma subunits |
| 09/14/2006 | US20060205014 Detecting and measuring anti-glycan antibodies; highly sensitive and specific serological testing method for definitively distinguishing IBD patients from those with other digestive diseases |
| 09/14/2006 | US20060205013 FET-type biosensor with surface modification |
| 09/14/2006 | US20060205012 Diagnostic test |
| 09/14/2006 | US20060205011 Combinatorial artificial receptors including tether building blocks on scaffolds |
| 09/14/2006 | US20060205010 Methods of host cell protein analysis |
| 09/14/2006 | US20060205009 Methods of assessing endothelial dysfunction using acute transient responese following fat administration |
| 09/14/2006 | US20060205006 PCR method and related apparatus |
| 09/14/2006 | US20060205005 Artificial red blood cells |
| 09/14/2006 | US20060205003 Methods, systems, and software for identifying functional biomolecules |
| 09/14/2006 | US20060205002 Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins |
| 09/14/2006 | US20060204998 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 09/14/2006 | US20060204996 Method of designing primer and probe sets, primer and probe set designed by the method, kit comprising the sets, computer readable medium recorded thereon program to execute the method, and method of identifying target sequence using the sets |
| 09/14/2006 | US20060204995 Method of designing probe set, probe set designed by the method, microarray comprising the probe set, computer readable medium recorded thereon program to execute the method, and method of identifying target sequence using the probe set |
| 09/14/2006 | US20060204987 Applications with and methods for producing selected interstrand cross-links in nucleic acids |
| 09/14/2006 | US20060204984 biosensors; cationic polymers; peptide nucleic acids; point mutations; quantitative analysis |
| 09/14/2006 | US20060204983 Binding assay using binding agents with tail groups |
| 09/14/2006 | US20060204982 Novel compositions and methods for cancer |
| 09/14/2006 | US20060204981 Compositions for modulation of PARP and methods for screening for same |
| 09/14/2006 | US20060204968 Tools for diagnostics, molecular definition and therapy development for chronic inflammatory joint diseases |
| 09/14/2006 | US20060204967 Methods for identifying risk of breast cancer and treatments thereof |
| 09/14/2006 | US20060204966 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor |
| 09/14/2006 | US20060204960 Method for diagnosing diffuse-type gastric cancers |
| 09/14/2006 | US20060204959 Solid support having electrostatic layer and use thereof |
| 09/14/2006 | US20060204958 Methods for diagnosing htlv-i-mediated diseases |
| 09/14/2006 | US20060204954 Compositions and methods for binding agglomeration proteins |
| 09/14/2006 | US20060204951 Platelet biomarkers for the detection of disease |
| 09/14/2006 | US20060204510 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 09/14/2006 | US20060204505 Methods for identifying tumors responsive to treatment with HER dimerization inhibitors (HDIs) |
| 09/14/2006 | US20060204499 Tumour necrosis factor binding ligands |
| 09/14/2006 | US20060204495 Isolation and identification of cross-reactive t cells |
| 09/14/2006 | US20060204494 Methionine sulfoxide antibodies |
| 09/14/2006 | US20060204439 Administering isotope labeled water to tissue; measurement, calibration |
| 09/14/2006 | US20060204435 Detection, imaging, and depletion of intracellular pathogens |
| 09/14/2006 | US20060204400 Process for separation of dispersions and an apparatus |
| 09/14/2006 | US20060204068 Method for quantitative video-microscopy and associated system and computer software program product |
| 09/14/2006 | US20060203247 Apparatus and method for evaluating the interior quality of fruits and vegetables |
| 09/14/2006 | US20060203226 Flow-cytometry-based hematology system |
| 09/14/2006 | US20060203225 Method and apparatus for direct spectrophotometric measurements in unaltered whole blood |
| 09/14/2006 | US20060202838 Method and apparatus for remote blood alcohol monitoring |
| 09/14/2006 | US20060202837 Method and apparatus for remote blood alcohol monitoring |
| 09/14/2006 | US20060202836 Method and apparatus for remote blood alcohol monitoring |
| 09/14/2006 | US20060201886 Method for determining the binding behavior of ligands which specifically bind to target molecules |
| 09/14/2006 | US20060201810 Automated laboratory system |